Antibodies come back from the brink
- 1 November 1998
- journal article
- research article
- Published by Springer Nature in Nature Biotechnology
- Vol. 16 (11) , 1015-1016
- https://doi.org/10.1038/3460
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- An efficient route to human bispecific IgGNature Biotechnology, 1998
- Synthetic human antibodies and a strategy for protein engineeringFEBS Letters, 1998
- Antibody phage display technology and its applicationsImmunotechnology, 1998
- Monoclonal antibody therapy for resected Dukes' C colorectal cancer: seven-year outcome of a multicenter randomized trial.Journal of Clinical Oncology, 1998
- Retargeting serum immunoglobulin with bispecific diabodiesNature Biotechnology, 1997
- Clinical evidence of efficient tumor targetting based on single–chain Fv antibody selected from a combinatorial libraryNature Medicine, 1996
- Man-made antibodiesNature, 1991
- The Croonian Lecture, 1989 Antibodies: a paradigm for the biology of molecular recognitionProceedings of the Royal Society of London. B. Biological Sciences, 1990
- Hybrid hybridomas and their use in immunohistochemistryNature, 1983
- Continuous cultures of fused cells secreting antibody of predefined specificityNature, 1975